Abstract

Cordycepin, extracted from the medicinal mushroom Cordyceps militaris, was shown to induce cancer cell apoptosis. Yet its anticancer function was limitedly evaluated, and the mechanism was not entirely elucidated. In this study, we demonstrated the effectiveness of cordycepin in inducing apoptosis in HeLa cells and investigated its apoptosis-inducing mechanism through label-free surface-enhanced Raman spectroscopy (SERS). SERS spectral changes revealed detailed molecular changes in both early and late stages of apoptosis. Importantly, SERS characteristic peaks at 805 and 1438 cm−1, which were assigned to RNA, continued to decrease significantly from early to late apoptosis stages. It indicated that cordycepin induced HeLa cell apoptosis mainly through interfering with RNA production, potentially by restraining the translation of RNA encoding ribosomal proteins. Meanwhile, apoptotic cells and their apoptosis stage could be easily differentiated by SERS-based principal component analysis (PCA). Furthermore, the morphological changes of early and late-stage apoptotic cells were illustrated by differential interference contrast and fluorescence microscopic imaging. Therefore, the natural ingredient, cordycepin, could serve as a promising anticancer candidate. Our biological model of cell apoptosis in vitro, the non-invasive and rapid SERS technique, combined with PCA analysis, could be a powerful tool in the investigation of cell apoptosis mechanisms and anticancer drug screening.

Highlights

  • Every year, approximately 527,600 women are newly diagnosed with cervical cancer, and265,700 people die of cervical cancer [1]

  • Our results showed that cordycepin potentially induced HeLa cell apoptosis through restraining the translation of RNA encoding ribosomal proteins

  • This study presented structural and biochemical changes in cordycepin-induced HeLa cell apoptosis and investigated its apoptosis-inducing mechanism

Read more

Summary

Introduction

Approximately 527,600 women are newly diagnosed with cervical cancer, and265,700 people die of cervical cancer [1]. Many efforts have been made to find or develop efficient anticancer drugs to treat cervical cancer and promote the survival rate [2]. The anticancer effect and mechanism of drugs were usually investigated through their performance in inducing cancer cell apoptosis [3,4,5]. Cervical cancer cells, i.e., HeLa cells, were widely used in drug-induced apoptosis studies to evaluate the anticancer effects and to investigate the anticancer mechanism of a drug or compound [6,7,8]. Extracting active anticancer compounds from natural substances has attracted much attention due to their simple composition, strong stability, high safety, and low irritation [9,10].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call